Mpox Response In Democratic Republic Of Congo Hindered By Stigma, Regulatory Hurdles, Officials Say

Reuters (12/5, Rigby) reports, “Vaccines and treatments that could help tackle an mpox epidemic in the Democratic Republic of Congo are lying unused outside the country despite a death rate far higher than from the global outbreak that began last year.” The article adds, “Stigma, regulatory hurdles and competing disease outbreaks are all factors holding back the response, according to almost a dozen scientists, public health officials and drugmakers involved.”